Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 15 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMA DISCOUNT from Anderlecht, company number BE0769949871, closed financial year 2025 with a result of € -6,696 after tax. For that financial year PHARMA DISCOUNT recorded a gross margin of € -3,986 and equity of € -24,526. Compared with financial year 2024, the result moved from € -313 to € -6,696. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ -24,526
▼ € 6,696 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -6,696
▼ 2039 % more loss than in 2024
Profit after tax over the fiscal year.
€ 929
▼ 77% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -30,526.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 3,001
▼ 46% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -7,208 | € -6,458 | € 2,332 | € -3,986 | ▼ € 6,318 |
| Profit after taxes | € -9,277 | € -10,666 | € -313 | € -6,696 | ▼ € 6,383 |
| Equity | € -6,852 | € -17,518 | € -17,831 | € -24,526 | ▼ € 6,696 |
| Total debts | € 34,077 | € 32,191 | € 32,730 | € 33,796 | ▲ 3% |
| Cash | € 12,535 | € 2,632 | € 4,063 | € 929 | ▼ 77% |
| Retained profit | € -12,852 | € -23,518 | € -23,831 | € -30,526 | ▼ € 6,696 |
| Balance sheet total | € 27,225 | € 14,673 | € 14,899 | € 9,269 | ▼ 38% |
Key figures of PHARMA DISCOUNT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA DISCOUNT?
What happened at PHARMA DISCOUNT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6,696. filed late Source: NBB ↗
- New establishment in Vorst. KBO
- Start of the company according to the CBE. KBO
- ALI EMDADI MILAD became a director. NBB
- ZACHARIA BOUMEDIENNI became a director. NBB
In short
From € 9,277 loss in 2022 to € 6,696 loss in 2025.
A new publication or filing at PHARMA DISCOUNT? We notify you, reason included.
Follow PHARMA DISCOUNTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMA DISCOUNT are ALI EMDADI MILAD and ZACHARIA BOUMEDIENNI. The same people are also behind PHARMATRUST, PHARMACIE MONTENEGRO and Pharmacie Armée Britannique. ALI EMDADI MILAD is also behind PHARMALAW.
Directors
According to the 2025 annual accounts
ALI EMDADI MILAD
Director
Also active at: PHARMALAW, PHARMATRUST, PHARMACIE MONTENEGRO, Pharmacie Armée Britannique
since 2021
ZACHARIA BOUMEDIENNI
Director
Also active at: PHARMATRUST, PHARMACIE MONTENEGRO, Pharmacie Armée Britannique
since 2021
Establishments
Establishment units
Physical locations of this company
Agavendreef 9
1070 Anderlecht
Brits Tweede Legerlaan 20 box B
1190 Vorst
Active since 22 June 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0769.949.871
- VAT number
- BE 0769.949.871
- Registered office
- Agavendreef 9, 1070 Anderlecht
- Names & denominations
- PHARMA DISCOUNT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 June 2021
- Peppol
- Active · Active since 15 Sept 2025
- Contact
- [email protected] +32484431889
- Activities · NACE
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Detailhandel in farmaceutische producten